Looks like you’re on the UK site. Choose another location to see content specific to your location

Home Industry News Agilent to combine life sciences and diagnostics business

Agilent to combine life sciences and diagnostics business

24th September 2013

Agilent Technologies has announced that it will be combining its life sciences group with its diagnostics and genomics business as part of a major corporate restructuring.

Lars Holmkvist has been named as the new group's president and senior vice-president of Agilent, moving up from his previous role of diagnostics and genomics group head.

He has been with the company since June 2012, when Agilent completed the acquisition of Dako, where he had served as chief executive officer (CEO) since 2009.

His promotion takes effect immediately and comes after Agilent unveiled plans to split the group into two independent firms, with one focusing on life sciences, diagnostics and applied markets and the other focusing on electronic measurements.

The Agilent name will be retained by the life science-oriented company, with Mr Holmkvist leading its new life sciences and diagnostics division, while Mike McMullen will continue to be responsible for the chemical analysis group.

William Sullivan, Agilent's president and CEO, said: "We are creating a new Agilent with a simplified structure that can move quickly to develop and deliver industry-leading total workflow solutions for our customers."ADNFCR-8000103-ID-801641492-ADNFCR

We currently have 6 jobs available in Pharmacy industry, find your perfect one now.

Stay informed

Receive the latest industry news, Tips
and straight to your inbox.